Mystic Asset Management’s Zevra Therapeutics ZVRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.37M	Buy	361,283 +14,756	+4%	+$133K	0.78%	36
2025 Q4	$3.1M	Sell	346,527 -125	-0%	-$1.18K	0.7%	37
2025 Q3	$3.3M	Hold	346,652	–	–	0.74%	35
2025 Q2	$3.05M	Buy	346,652 +7,750	+2%	+$62.9K	0.74%	38
2025 Q1	$2.54M	Buy	338,902 +25,555	+8%	+$203K	0.67%	42
2024 Q4	$2.61M	Buy	313,347 +5,900	+2%	+$50.4K	0.7%	38
2024 Q3	$2.13M	Buy	307,447 +9,500	+3%	+$64.5K	0.81%	35
2024 Q2	$1.46M	Buy	297,947 +31,650	+12%	+$150K	0.59%	53
2024 Q1	$1.54M	Buy	266,297 +35,514	+15%	+$218K	0.64%	50
2023 Q4	$1.51M	Buy	230,783 +27,500	+14%	+$129K	0.72%	43
2023 Q3	$980K	Buy	203,283 +14,750	+8%	+$73.6K	0.55%	59
2023 Q2	$962K	Buy	188,533 +11,000	+6%	+$59.3K	0.52%	68
2023 Q1	$976K	Buy	177,533 +1,650	+0.9%	+$8.73K	0.54%	66
2022 Q4	$807K	Buy	175,883 +11,000	+7%	+$55.9K	0.46%	75
2022 Q3	$1.03M	Buy	164,883 +7,350	+5%	+$41.6K	0.66%	56
2022 Q2	$702K	Buy	157,533 +53,452	+51%	+$244K	0.43%	79
2022 Q1	$523K	Buy	104,081 +32,100	+45%	+$204K	0.28%	101
2021 Q4	$626K	Buy	+71,981	New	+$642K	0.3%	93